OWONIKOKO, T.; PAPADOPOULOS, K.; JOHNSON, M.; AL., et. Phase 1 Study of Cemiplimab, a Human Monoclonal Anti-PD-1 Antibody, in Patients with Unresectable Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-up Efficacy and Safety Data. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, n. 2, p. 169, 2019. DOI: 10.25251/skin.3.2.9. Disponível em: https://skin.dermsquared.com/skin/article/view/526. Acesso em: 10 jan. 2025.